Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy

Nature Clinical Practice Urology volume 1, pages 26–30 (2004)Cite this article

Abstract

It is estimated that in 2004 there will be 35,700 new cases of, and 12,480 deaths from, kidney cancer in the US.1 Since 1950 there has been a 126% increase in the incidence of renal cancer and a 36.5% increase in annual associated mortality.2 In the past two decades, our understanding of tumors arising from the renal cortex has dramatically expanded owing to advances in cytogenetics and histopathological reclassification. It is now known that renal cell carcinoma (RCC) is a family of neoplasms that possess unique molecular and cytogenetic defects, with 90% of metastases emanating from conventional clear cell carcinoma subtype. In addition to advancing our understanding of RCC, improved abdominal imaging technology has caused a migration of tumor stage and alteration of surgical strategies, with tumors commonly being diagnosed at an earlier stage. Despite these advances, the prognosis for patients with metastatic RCC is poor. Studies that examine combinations of surgery and systemic therapy aim to improve survival in this high-risk group.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Jemal A et al. (2004) Cancer Statistics 2004. CA Cancer J Clin 54: 8–29

    Article  Google Scholar 

  2. Pantuck AJ et al. (2001) The changing natural history of renal cell carcinoma. J Urol 166: 1611–1623

    Article  CAS  Google Scholar 

  3. Russo P (2000) Renal cell carcinoma: Presentation, staging, and surgical treatment. Semin Oncol 27: 160–176

    CAS  PubMed  Google Scholar 

  4. Russo P (2004) Partial nephrectomy: The contemporary gold standard operation for T1 renal masses. Am J Urol Rev 2: 214–222

    Google Scholar 

  5. Motzer RJ and Russo P (2000) Systemic therapy for renal cell carcinoma. J Urol 163: 408–417

    Article  CAS  Google Scholar 

  6. Iliopoulos O and Eng C (2000) Genetic and clinical aspects of familial renal neoplasms. Semin Oncol 27: 138–149

    CAS  PubMed  Google Scholar 

  7. Linehan WM et al. (2003) The genetic basis of cancer of the kidney. J Urol 170: 2163–2172

    Article  CAS  Google Scholar 

  8. Toro JR et al. (1999) Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol 135: 1195–1202

    CAS  PubMed  Google Scholar 

  9. Prowse AH et al. (1997) Somatic inactivation of the VHL gene in Von Hippel Lindau disease tumors. Am J Hum Genet 60: 765–771

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Herman JG et al. (1994) Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700–9704

    Article  CAS  Google Scholar 

  11. Gnarra JR et al. (1994) Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 7: 85–90

    Article  CAS  Google Scholar 

  12. Iliopoulos O et al. (1996) Negative regulation of hypoxia–inducible genes by the von Hippel–Lindau protein. Proc Natl Acad Sci USA 93: 10595–10599

    Article  CAS  Google Scholar 

  13. Wykoff CC et al. (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075–7083

    CAS  PubMed  Google Scholar 

  14. Beck SD et al. (2004) Renal cortical tumors: variable metastatic potential. Ann Surg Oncol 11: 71–77

    Article  Google Scholar 

  15. Motzer RJ et al. (2002) Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear cell histology. J Clin Oncol 20: 2376–2381

    Article  Google Scholar 

  16. Fossa SD (2000) Interferon in metastatic renal cell carcinoma. Semin Oncol 27: 187–193

    CAS  PubMed  Google Scholar 

  17. Motzer RJ et al. (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17: 2859–2867

    Article  Google Scholar 

  18. Motzer RJ et al. (2000) Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. J Clin Oncol 18: 1928–1935

    Article  CAS  Google Scholar 

  19. Motzer RJ et al. (2004) Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 22: 454–463

    Article  Google Scholar 

  20. Kattan MW et al. (2001) A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166: 63–67

    Article  CAS  Google Scholar 

  21. Lee CT et al. (2002) Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol 7: 135–140

    Article  Google Scholar 

  22. Barney JD and Churchill EJ (1939) Adenocarcinoma of the kidney with metastasis to the lung: cured by nephrectomy and lobectomy. J Urol 42: 269–276

    Article  Google Scholar 

  23. Giuliani L et al. (1990) Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 143: 468–473

    Article  CAS  Google Scholar 

  24. Golimbu M et al. (1986) Renal cell carcinoma: survival and prognostic factors. Urology 27: 291–301

    Article  CAS  Google Scholar 

  25. Maldazys JD and deKernion JB (1986) Prognostic factors in metastatic renal carcinoma. J Urol 136: 376–379

    Article  CAS  Google Scholar 

  26. Neves RJ et al. (1988) Metastatic renal cell cancer and radical nephrectomy: identification of prognostic factors and patient survival. J Urol 139: 1173–1176

    Article  CAS  Google Scholar 

  27. Kjaer M (1987) The treatment and prognosis of patients with renal adenocarcinoma with solitary metastasis. 10 year survival results. Int J Radiat Oncol Biol Phys 13: 619–621

    Article  CAS  Google Scholar 

  28. Kierney PC et al. (1994) Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol 1: 345–352

    Article  CAS  Google Scholar 

  29. Pogrebniak HW et al. (1992) Renal cell carcinoma: resection of solitary and multiple metastases. Ann Thorac Surg 54: 33–38

    Article  CAS  Google Scholar 

  30. Kavolius JP et al. (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16: 2261–2266

    Article  CAS  Google Scholar 

  31. Wronski M et al. (1996) Surgical resection of brain metastases from renal cell carcinoma. Urology 47: 187–193

    Article  CAS  Google Scholar 

  32. Kim SH et al. (1998) The role of surgery in the treatment of adrenal metastasis. Cancer 82: 389–394

    Article  CAS  Google Scholar 

  33. Montie JE et al. (1977) The role of adjuvant nephrectomy in patients with metastatic renal cell carcinoma. J Urol 117: 272–275

    Article  CAS  Google Scholar 

  34. Walther MM et al. (1997) Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma. J Urol 158: 1675–1678

    Article  CAS  Google Scholar 

  35. Rackley R et al. (1994) The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma. J Urol 152: 1399–1403

    Article  CAS  Google Scholar 

  36. Sella A et al. (1993) Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma. J Urol 149: 19–21

    Article  CAS  Google Scholar 

  37. Flanigan RC et al. (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal cell carcinoma. N Engl J Med 345: 1655–1659

    Article  CAS  Google Scholar 

  38. Mickisch GHJ et al. (2001) Radical nephrectomy plus interferon alfa-based immunotherapy compared with interferon alfa alone in metastatic renal cell carcinoma: a randomized trial. Lancet 358: 966–970

    Article  CAS  Google Scholar 

  39. Flanigan RC et al. (2004) Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis. J Urol 171: 1071–1076

    Article  Google Scholar 

  40. Walther MM et al. (1999) Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study. Urology 53: 496–501

    Article  CAS  Google Scholar 

  41. Bromwich E et al. (2002) Cytoreductive nephrectomy: is it a realistic option in patients with renal cancer? BJU Int 89: 523–52555

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Associate Attending Surgeon in the Department of Urology at Memorial Sloan-Kettering Cancer Center, New York

    Paul Russo

Authors
  1. Paul Russo
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Paul Russo.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russo, P. Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy. Nat Rev Urol 1, 26–30 (2004). https://doi.org/10.1038/ncpuro0029

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpuro0029

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing